ANISBEL HORNIA SILVA: Open Payments
NPI 1740763036 · SOUTH GATE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,389 in 125 payments from 14 companies in 2025. Trend: 2023 $267 · 2024 $741 · 2025 $2,389
Food & beverage: $2,354Education: $35
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 26 | $484 |
| Axsome Therapeutics, Inc. | 12 | $325 |
| Alkermes, Inc. | 16 | $300 |
| ABBVIE INC. | 21 | $286 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $204 |
| Teva Pharmaceuticals USA, Inc. | 10 | $159 |
| Neurocrine BioSciences, Inc. | 6 | $157 |
| Vanda Pharmaceuticals Inc. | 7 | $153 |
| Supernus Pharmaceuticals, Inc. | 4 | $93 |
| Janssen Pharmaceuticals, Inc | 3 | $70 |
Products named: REXULTI, Auvelity, ARISTADA, VRAYLAR, CAPLYTA, INGREZZA, FANAPT, AUSTEDO XR.
Industry payments across CA — which companies pay providers there.
